3 min read
Cleerly: May 23, 2023
"It's very scary because I had a lot of patients and even friends and neighbors that had heart attacks, and we thought they were healthy by eating...
4 min read
Cleerly: February 27, 2023
Quantification of coronary artery disease (CAD) burden and atherosclerotic plaque type has been shown to be the strongest determinant of future risk...
4 min read
Cleerly: February 13, 2023
Heart disease is the cause of death for 700,000 Americans1 and nearly 17.9 million people worldwide every year.2 While some of these individuals...
4 min read
Cleerly: January 17, 2023
Current methodologies for coronary artery disease (CAD) screening often result in misidentification of low-risk patients and may submit patients to...
2 min read
Cleerly: January 17, 2023
Cleerly is making the future of cardiovascular care possible through easy-to-use, clinically proven technology that effortlessly integrates into...
3 min read
Cleerly: January 17, 2023
Current methodologies for screening for coronary artery disease (CAD) at the primary care provider’s office are often limited. And once heart disease...
2 min read
Cleerly: January 10, 2023
Cleerly makes early detection of heart disease risk possible through our AI-enabled analysis of coronary computed tomography angiography (CCTA)...
3 min read
Cleerly: October 18, 2022
Half of patients who have a heart attack don't show symptoms prior to their event. A new standard of precision care that emphasizes comprehensive...
3 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: September 19, 2022
Myocardial perfusion, also known as a "stress test", is today's go-to-method for detecting coronary artery disease - despite limited performance.
7 min read
James K. Min, MD, FACC, FESC, MSCCT, Founder & CEO of Cleerly: August 1, 2022
The current approach to cardiovascular care is flawed for two reasons. One is the lack of a disease-based care paradigm with a focus on actual heart...
